invest conclus given investor concern quarterli ep
head today result better fear catalyz
peer group today result confer call increas
ep maintain ep estim street
current like tickl post today result pt
unchang still base price-to-earnings ep estim believ unh
result go long way toward remov one two recent overhang mco
fundament less question investor polit risk still preval
reassur trend commentari unh in-lin fairli clean
alon provid relief peer management alter prior
view prior confus around management note
medic cost remain well-control commerci cost trend run
lower half initi rang given investor heighten
concern commerci medic cost industri follow result unh
favor revis today elimin concern government side state
cost trend remain low single-digit rang provid reassur
investor medicaid pressur note sever compani manag
prior earn preview trim ep
consensu estim time base
math see figur mgmt comment impli ep estim
modestli estim prior consensu
importantli manag indic abl grow core underli ep
exclud hif headwind lower end lt rang
importantli still within rang note treatment hif relat
ep outlook similar ep outlook see figur usual
provid detail outlook investor day nyc tue dec
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
overweight price target
group base price-to-earnings ep
believ deserv premium valuat
diversifi peer due faster earn growth
stem optum medicar
upsid case reflect favor medic
cost trend outlook increas share gain
uhc optum
downsid case reflect risk associ
increas cost trend agress commerci price
pbm regulatori risk
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
ep outlook novemb investor present
ep guidanc hif ep adjust earn growth low-end lt target consensu ep prior barclay
 annual incom statement compani compani yr/yr compani medic loss product product profit total incom intang amort pre-tax rate minor interest net incom exclud check ep fulli dilut share barclay
 ern membership unit healthcar part mn employ metricscar bnoptum bncare segmentoptumhealth consum mnoptuminsight bnoptumrx adj mngroup target oper incom loss bpsoper bpsdividend paid share repurchas wtd averag dilut s/o share barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc refinitiv reflect close price relev trade market may last
avail price time public
